top of page

hEDS Posts

Search

Mitochondrial Dysfunction in hEDS: What It Means and Why It Matters

Writer: zebrathemiddleaged
zebrathemiddleaged
Oct 9
5 min read

Fatigue in hypermobile Ehlers-Danlos syndrome can feel out of proportion to the activity that caused it. A short walk, a medical appointment, or a poor night of sleep may lead to heavy limbs, brain fog, pain flares, and days of recovery. One possible piece of that puzzle is mitochondrial dysfunction.


Mitochondria are often called the powerhouses of the cell, but that nickname is too simple. They help turn food and oxygen into usable energy, manage oxidative stress, influence inflammation, and help cells respond to demand. When they do not work well, the body may struggle to produce and use energy efficiently.


In hEDS, this topic is still developing. Some research reports growing evidence that suggests energy metabolism may help explain why some people with hEDS experience severe fatigue, exercise intolerance, dizziness, and slow recovery.


Anyone with new, severe, or worsening symptoms should speak with a qualified clinician.


Close-up view of a mitochondria model held in a hand
Mitochondria help cells turn fuel into usable energy.

What mitochondrial dysfunction means in plain language


Mitochondrial dysfunction means cells are having trouble making, moving, or using energy in the usual way. This can happen for many reasons. The problem may involve the enzymes that produce ATP, the oxygen supply to tissues, nutrient availability, oxidative stress, or the signals that tell cells when to increase energy production.


ATP is the main energy currency of the cell. Muscles need it to contract. Nerves need it to send signals. The gut, immune system, and heart all depend on it. When energy production falls short, symptoms can show up in different body systems.

Common symptoms linked with poor cellular energy production include:


  • Profound fatigue that does not improve with ordinary rest

  • Muscle heaviness, aching, or early weakness

  • Exercise intolerance or post-exertional symptom worsening

  • Brain fog and trouble concentrating

  • Headaches or light sensitivity in some people

  • Temperature sensitivity or feeling “wired but tired”


These symptoms can also come from dysautonomia, anemia, sleep disorders, thyroid disease, chronic pain, medication effects, and many other causes. That overlap is one reason this topic is complex.


Why mitochondria matter in hEDS


Hypermobile Ehlers-Danlos syndrome affects connective tissue, joint stability, pain processing, and often the autonomic nervous system. Many people with hEDS also live with conditions such as postural orthostatic tachycardia syndrome, migraine, gastrointestinal dysmotility, mast cell activation symptoms, and chronic fatigue.


Mitochondria may matter because they sit at the crossroads of several hEDS-related problems.


Loose or fragile connective tissue can make muscles work harder to stabilize joints. That extra work can raise energy demand. If the autonomic nervous system has trouble regulating heart rate, blood vessel tone, and blood flow, muscles and the brain may not receive oxygen as efficiently during activity. Pain also has an energy cost. The nervous system stays on alert, sleep may suffer, and recovery becomes harder.


Mitochondria are not the whole story. They are one part of a larger system that includes connective tissue, circulation, nerves, immune signaling, hormones, and metabolism.


Eye-level view of a person resting after gentle physical therapy
Fatigue after activity can reflect many overlapping body systems.

Possible causes of mitochondrial problems in hEDS


Researchers are still sorting out whether mitochondrial changes in hEDS are primary, secondary, or both. Several pathways may contribute.


Genetic factors may play a role


Classical mitochondrial diseases can result from variants in mitochondrial DNA or nuclear genes that control mitochondrial function. hEDS is different. Unlike some other Ehlers-Danlos types, hEDS does not yet have one genetic marker used for diagnosis.


That does not rule out genetic influence. Experts generally view hEDS as likely involving multiple genes, with varied expression from person to person. Some of those genes may affect connective tissue structure, pain signaling, autonomic regulation, immune tone, or cellular energy pathways. For now, this remains an active research area rather than a settled answer.


Energy demand may exceed energy supply


For many people with hEDS, the body may spend extra energy on basic movement. Unstable joints can require constant muscle guarding. Poor proprioception, the body’s sense of joint position, can make movement less efficient. Deconditioning may develop after injury, pain, or repeated post-exertional crashes, which can further reduce exercise tolerance.

This can create a frustrating loop:


Joint instability increases muscle effort

Pain and dysautonomia disrupt sleep and blood flow

Activity causes symptom flares

Higher effort increases energy demand

Poor recovery lowers activity tolerance

Avoidance leads to further deconditioning


Breaking that loop usually takes careful pacing, symptom-informed rehabilitation, and treatment of related conditions. Pushing through can backfire for some people, especially when post-exertional malaise is present.


Environmental stress can strain mitochondria


Mitochondria respond to stress. Infection, inflammation, poor sleep, nutrient deficiencies, certain medications, toxin exposure, chronic emotional stress, and prolonged inactivity can all affect energy metabolism.


This does not mean lifestyle factors “cause” hEDS. It means the cellular energy system is sensitive to the body’s overall state. A person with hEDS may have less reserve when several stressors stack up at once.


Overhead view of a simple plate with protein, colorful vegetables, and water
Nutrition supports energy metabolism but does not replace medical care.

What recent research suggests


Recent research has started to look beyond joints and collagen to broader biology in hEDS and hypermobility spectrum disorders. Studies using exercise testing, metabolomics, muscle evaluation, and autonomic testing have reported patterns that point toward altered oxygen use, abnormal exertional responses, and differences in metabolic markers in some patients.


The findings are not yet uniform. Some studies include small groups. Diagnostic criteria can differ. Many participants have overlapping conditions such as POTS, long COVID, migraine, or chronic fatigue syndrome, which can make it hard to know what belongs specifically to hEDS.


Still, the direction is meaningful. Researchers increasingly describe hEDS as a multisystem condition, not only a joint disorder. Many clinicians who specialize in complex chronic illness also emphasize that fatigue in hEDS should not be dismissed as simple inactivity or anxiety. It may reflect measurable problems in circulation, autonomic function, sleep, inflammation, pain processing, and cellular energy regulation.


A balanced expert view is this: mitochondrial dysfunction may be a contributor, but it is unlikely to be a single explanation for every symptom or every patient.


What this means for care and daily life


There is no standard mitochondrial treatment for hEDS. Care usually focuses on identifying treatable contributors and building capacity without triggering crashes.


A clinician may evaluate for common fatigue drivers such as iron deficiency, B12 deficiency, thyroid disease, sleep apnea, medication side effects, inflammatory illness, POTS, and nutritional gaps. In selected cases, referral to genetics, neurology, cardiology, or metabolic specialists may be appropriate.

Practical support often includes:


  • Pacing activity and avoiding repeated overexertion

  • Physical therapy that respects joint instability and autonomic symptoms

  • Hydration and salt strategies when recommended for dysautonomia

  • Sleep treatment when sleep quality is poor

  • Adequate protein, calories, and key micronutrients

  • Pain management that reduces constant nervous system strain


Supplements such as CoQ10, riboflavin, L-carnitine, magnesium, or creatine are sometimes discussed in mitochondrial health. Evidence varies, and they are not risk-free for everyone. They can interact with medications or worsen certain symptoms, so it is best to review them with a clinician.


Side view of a person checking heart rate during a slow walk outdoors
Gentle pacing can help match activity to available energy.

Mitochondrial dysfunction in hEDS is a promising but unfinished area of study. It offers a useful way to think about fatigue, exercise intolerance, brain fog, and slow recovery, especially when those symptoms seem out of proportion to visible joint problems.


The most helpful approach is not to reduce hEDS to one cause. Connective tissue, blood flow, the autonomic nervous system, pain, sleep, immune signaling, and cellular energy all interact. Understanding those connections can lead to better questions, better testing, and care that takes fatigue seriously.


For now, the key message is simple: energy problems in hEDS are real for many people, and they deserve careful, science-informed attention and continued research.


 
 
 

Comments


Stay Connected

Disclaimer

This site is strictly a blog and information website about HEDS. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

  • Facebook
  • Instagram
  • Link
  • Link
bottom of page